European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.18% to 1,338.75 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and electronics conglomerate Philips (PHG), which rose 2.2% and 1.6% respectively. They were followed by financial services companies Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria (BBVA), which were up 1.4% and 1% respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company DBV Technologies (DBVT), which lost 10% and 3.4% respectively. They were followed by medical device maker EDAP TMS (EDAP) and the pharmaceutical company Sanofi (SNY), which dropped 4.2% and 1.8% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm (TCBP) and Trinity Biotech (TRIB), which advanced 24.1% and 10.4% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics (BCYC) and pharmaceutical company Mereo BioPharma Group (MREO), which increased 5% and 3.2% respectively.
The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and pharmaceutical company AstraZeneca (AZN), which fell 3.4% and 1.6% respectively. They were followed by telecommunications operator Vodafone Group (VOD), which was down 1.5%.
Price: 3.72, Change: +0.08, Percent Change: +2.23
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。